48th week of 2013 patent applcation highlights part 51 |
Patent application number | Title | Published |
20130317158 | USE OF CALCIUM HYPOPHOSPHITE AS A FILLER TO INCREASE MECHANICAL PROPERTIES OF A POLYAMIDE COMPOSITION - The use of a heat stabilized calcium hypophosphite as a filler to increase the mechanical properties of a polyamide composition is described. The composition can also involve reinforcing and/or bulking filler and/or impact modifier agents. Using such a filler one can obtain a polyamide composition having very good mechanical performance with the calcium hypophosphite having a low degree of phoshpine generation. | 2013-11-28 |
20130317159 | Reinforced Poly(Arylene Sulfide) Compositions - The present application relates reinforced poly(arylene sulfide) compositions and processes of producing the reinforced poly(arylene sulfide) compositions. The reinforced poly(arylene sulfide compositions can be prepared by blending the reinforcing agent with the poly(arylene sulfide) or by including the reinforcing agent in the process to produce the poly(arylene sulfide). Reinforcing agents which can be utilized are graphenes (e.g., single-walled carbon nanotubes). The inclusion of the graphene reinforcing agent in the poly(arylene sulfide) composition affects the crystallization properties and/or the conductivity of the melt processed poly(arylene sulfide) compositions. | 2013-11-28 |
20130317160 | HETEROPHASIC POLYPROPYLENE COPOLYMER COMPOSITION - Heterophasic polypropylene composition comprising
| 2013-11-28 |
20130317161 | Random Mat and Fiber-Reinforced Composite Material - There is provided a random mat of the present invention including: reinforcing fibers having an average fiber length of 5 to 100 mm; and a thermoplastic resin,
| 2013-11-28 |
20130317162 | PERFLUOROELASTOMER GELS - Perfluoroelastomeric gel having the following properties:
| 2013-11-28 |
20130317163 | PHA COMPOSITIONS COMPRISING PBS AND PBSA AND METHODS FOR THEIR PRODUCTION - Compositions of PHAs with PBS and/or PBSA are described and methods of making the same. | 2013-11-28 |
20130317164 | MALEIC ANHYDRIDE COPOLYMERS AS SOLUBLE SUPPORT MATERIAL FOR FUSED DEPOSITION MODELLING (FDM) PRINTER - The invention relates to a novel support material for the fused deposition modelling process for producing three-dimensional objects. The invention relates more particularly to a 3D printing process involving support materials which are easier to remove than in the prior art. The support materials according to the invention are styrene-maleic anhydride copolymers for example. | 2013-11-28 |
20130317165 | CROSSLINKED RESIN FINE PARTICLE AND COATING COMPOSITION - The object of the present disclosure is to provide a crosslinked resin fine particle which has a particle diameter small enough to be used suitably for the purpose of viscosity control and can be produced inexpensively. Crosslinked resin fine particles obtained by reacting a vinyl monomer composition comprising:
| 2013-11-28 |
20130317166 | ALPHA-OLEFIN POLYMER AND METHOD FOR PRODUCING THE SAME - An α-olefin polymer satisfying the following (1) to (4): (1) the average carbon-atom number of α-olefins constituting the polymer is 6.0 or more and 14 or less; (2) the molecular weight distribution (Mw/Mn)≦2.0; (3) 3000≦weight average molecular weight (Mw)≦600000; and (4) (Log | 2013-11-28 |
20130317167 | AQUEOUS POLYURETHANE RESIN DISPERSION AND USE THEREOF - An aqueous polyurethane resin dispersion exhibits excellent drying properties of coating films and gives coating films having high water resistance and on the other hand showing a high rate of swelling with respect to aqueous cleaning liquids to permit new application. The aqueous polyurethane resin dispersion is a dispersion of a polyurethane resin in an aqueous medium, the polyurethane resin being obtained by reacting (A) a polyurethane prepolymer obtained from (a) a polyisocyanate compound, (b) a polycarbonate polyol with a number average molecular weight of 400 to 3000, (c) an acidic group-containing polyol compound and (d) a blocking agent, with (B) a chain extender, the total content of urethane bonds and urea bonds being 7 to 15 wt %, the content of carbonate bonds being 15 to 40 wt %, the content of ether bonds being 0 wt %, the content of isocyanate groups bonded to the blocking agent being 0.2 to 2 wt %, each of these contents being based on solid contents, the acid value being 11 to 16 mg KOH/g, the weight average molecular weight being 25,000 to 60,000. A coating composition includes the dispersion. A polyurethane resin film is obtained by thermally drying a composition including the dispersion. | 2013-11-28 |
20130317168 | SCRATCH-RESISTANT, TRANSPARENT AND TOUGH COPOLYAMIDE MOULDING COMPOUNDS, MOULDED ARTICLES PRODUCED THEREFROM AND USES THEREOF - Disclosed are scratch-resistant, transparent and tough copolyamide moulding compounds distinguished by high scratch-resistance, excellent transparency and great toughness, which are suitable for producing transparent moulded articles or transparent coatings. The moulding compounds are obtained by polycondensation of a carboxylic acid mixture including at least one aliphatic dicarboxylic acid and at least one aromatic dicarboxylic acid with at least one cycloaliphatic diamine. Also disclosed are moulded parts or coatings produced from the copolyamide compounds. | 2013-11-28 |
20130317169 | RAPIDLY CURING COMPOUND HAVING GOOD ADHESIVE PROPERTIES - A curable compound is provided, which can be obtained as a mixture of at least two components to be stored separately, of which one component includes a silane-modified polymer and the component of a second component includes an acid or basic salt containing water of crystallization. An aminic adhesion promoter is contained in one or both components or a further component, with the stipulation that no component contains all three substances. Additionally, a method is provided for accelerating the curing of a silane-modified polymer, in which an acid or basic salt containing water of crystallization is added to the silane-modified polymer. | 2013-11-28 |
20130317170 | ALUMINUM METALLIC NANOPARTICLE-POLYMER NANOCOMPOSITES FOR ENERGY STORAGE - A nanoparticle composition comprising a substrate comprising aluminum nanoparticles, an Al | 2013-11-28 |
20130317171 | AQUEOUS POLYURETHANE RESIN DISPERSION AND USE THEREOF - An aqueous polyurethane resin dispersion is a dispersion of a polyurethane resin in an aqueous medium, the polyurethane resin being obtained by reacting (A) a polyurethane prepolymer obtained by reacting (a) a polyisocyanate compound, (b) a polyol compound including a polycarbonate polyol with a number average molecular weight of 400 to 3000, (c) an acidic group-containing polyol compound and (d) a blocking agent, with (B) a chain extender, the total content of urethane bonds and urea bonds being 7 to 15 wt %, the content of carbonate bonds being 15 to 40 wt %, the content of ether bonds being 0.5 to 5 wt %, the content of isocyanate groups bonded to the blocking agent being 0.2 to 2.0 wt %, each of these contents being based on solid contents, the acid value being 10 to 16 mg KOH/g. The aqueous polyurethane resin dispersion can form coating films which permit new application while exhibiting excellent water resistance and solvent resistance. A coating composition includes the dispersion. A polyurethane resin film is obtained by thermally drying a composition including the dispersion. | 2013-11-28 |
20130317172 | METHOD FOR IMMOBILIZING TEMPERATURE RESPONSIVE PROTEIN A - A method for manufacturing a carrier having temperature responsive protein A, which is protein A mutated such that a binding property to an antibody changes depending upon temperature, immobilized thereto, wherein the temperature responsive protein A has the binding property to the antibody in a first temperature region and no binding property to the antibody in a second temperature region; and the method comprises a step of immobilizing the temperature responsive protein A to a carrier surface at a temperature within the first temperature region in which the temperature responsive protein A has the binding property to the antibody. | 2013-11-28 |
20130317173 | COMPATIBILIZED POLYPROPYLENE HETEROPHASIC COPOLYMER AND POLYLACTIC ACID BLENDS FOR INJECTION MOLDING APPLICATIONSCOMPATIBILIZED POLYPROPYLENE HETEROPHASIC COPOLYMER AND POLYLACTIC ACID BLENDS FOR INJECTION MOLDING APPLICATIONS - Injection molded articles and process of forming the same are described herein. The processes generally include providing a polyolefin including one or more propylene heterophasic copolymers, the polyolefin having an ethylene content of at least 10 wt. % based on the total weight of the polyolefin; contacting the polyolefin with a polylactic acid and a reactive modifier to form a compatiblized polymeric blend, wherein the reactive modifier is produced by contacting a polypropylene, a multifunctional acrylate comonomer, and an initiator under conditions suitable for the formation of a glycidyl methacrylate grafted polypropylene (PP-g-GMA) having a grafting yield in a range from 1 wt. % to 15 wt. %; and injection molding the compatibilized polymeric blend into an article. | 2013-11-28 |
20130317174 | Thermoplastic Composition, Method of Producing the Same, and Articles Made Therefrom - A thermoplastic composition comprising from 60 percent to 99 percent by weight of one or more thermoplastic polymers; and from 40 percent to 1 percent by weight of an additive comprising a crosslinked (meth)acrylate polymer, wherein the crosslinked methylmethacrylate polymer comprises at least 99.5 percent by weight derived from methyl methacrylate units, and from greater than zero to less than 0.5 percent by weight derived from one or more multifunctional crosslinking monomers; wherein the crosslinked (meth)acrylate polymer has a volume average particle size of equal to or less than 1.0 micron; and wherein an article produced from the scratch-resistant thermoplastic composition has a hardness of greater than F is provided. Also provided are a method of making the thermoplastic composition, articles made from the polycarbonate composition, and a method of making the articles. | 2013-11-28 |
20130317175 | LIGHT DIFFUSING POLYMER COMPOSITION, METHOD OF PRODUCING THE SAME, AND ARTICLES MADE THEREFROM - A composition comprising: a blended product of: a matrix polymer; and from 0.05 to 2.5 wt % diffuser polymeric particles, wherein the diffuser polymeric particles are characterized by an average diameter from 2.0 to 8 micrometers, a particle size distribution such that at least 90 wt % of the polymer particles fall within ±30% of the volume average particle size, a refractive index, RI, from 1.50 to 1.55; a crosslinking level great than 4%; and wherein the diffuser polymeric particles are produced using at least one alkyl(meth)acrylate monomer copolymerized with from 5 wt % to 25 wt % crosslinking monomer selected from the group consisting of aliphatic crosslinking monomers, aromatic crosslinking monomers, and combinations thereof, and optionally, one or more comonomers selected from the group consisting of aryl(meth)acrylate monomers and monovinyl arenes is provided. | 2013-11-28 |
20130317176 | POLYISOPRENE, PREPARATION METHOD THEREOF, POLYISOPRENE RUBBER COMPOUNDS AND VULCANIZATE THEREFROM - The method for preparation of polyisoprene includes conducting polymerization reaction of isoprene in a first organic solvent under the presence of rare earth catalyst I and rare earth catalyst II, to obtain polyisoprene with bimodal molecular weight distribution, wherein the polymerization reaction conditions are controlled to ensure the peak molecular weight of the high molecular weight component fraction in the polyisoprene is 1×10 | 2013-11-28 |
20130317177 | OLEFIN COMPOSITION - Provided are an olefin composition, filler and an optoelectronic device. One illustrative olefin composition may be effectively used as a filling material for various optoelectronic devices. | 2013-11-28 |
20130317178 | ACTIVE POLYMERIC FILTERS - A polymer includes at least one pendant dioxirane moiety represented by Formula III or IV: | 2013-11-28 |
20130317179 | SUPPORTED QUATERNARY PHOSPHONIUM CATALYST, PREPARATON AND USE THEREOF - This invention relates to a supported quaternary phosphonium catalyst, preparation thereof and use thereof in producing dialkyl carbonates. The supported quaternary phosphonium catalyst of this invention has the following average molecular structure (I), and is characterized by a relatively high and stable catalyst activity. | 2013-11-28 |
20130317180 | CARBON DIOXIDE SORBENTS - Improved CO | 2013-11-28 |
20130317181 | POLYSILOXANE-POLYLACTIDE BLOCK COPOLYMER AND PREPARATION METHOD THEREOF - The present invention relates to a polysiloxane-polylactide block copolymer and a preparation method thereof, in which the polysiloxane-polylactide block copolymer has improved impact resistance and flexibility, compared to the conventional polylactide resins and can be prepared by ring-opening polymerization of lactide monomers in the presence of a polymerization initiator of polysiloxane. | 2013-11-28 |
20130317182 | PROCESS FOR MANUFACTURING BRANCHED AROMATIC POLYCARBONATE RESIN WITH DESIRED DEGREE OF BRANCHING - [Problem] To provide a process for manufacturing, easily and using a conventional branching agent, a branched aromatic polycarbonate resin which has both a sufficiently high molecular weight and a desired degree of branching. [Solution] A branched aromatic polycarbonate resin having a degree of branching (N value) controlled within a specific range is manufactured by subjecting an aromatic polycarbonate prepolymer that has a branched structure introduced using a specific amount of a branching agent to molecular-weight-increasing linking reaction with an aliphatic diol compound in the presence of a transesterification catalyst under the condition of a reduced pressure. The amount (A) of the branching agent used in adjusted on the basis of the correlation between the amount (A) of the branching agent used and the N value of the branched aromatic polycarbonate resin. | 2013-11-28 |
20130317183 | HYBRID POLYMER NETWORKS AS ULTRA LOW 'K' DIELECTRIC LAYERS - According to one embodiment, a polymeric material includes at least one polydimethylsiloxane (PDMS) polymer, and at least one polyhedral oligomericsilsequioxane (POSS) molecule. According to another embodiment, a method includes providing at least one polydimethylsiloxane (PDMS) polymer, providing at least one polyhedral oligomericsilsequioxane (POSS) molecule, and coupling the at least one PDSM polymer to the at least one POSS molecule to form a hybrid polymeric material. | 2013-11-28 |
20130317184 | CATALYST PRECURSOR AND CATALYST FOR THE HIGH-TEMPERATURE (CO)POLYMERIZATION OF ALPHA-OLEFIN - A precursor for the formation of catalysts for the (co)polymerization of α-olefins, comprising titanium, magnesium, at least one metal selected from hafnium and zirconium, aluminum and chlorine, obtained with a process comprising treatment with a siloxane compound. Said solid precursor, used in combination with a suitable co-catalyst in high-temperature (co)polymerization processes of α-olefins, shows an improved productivity, a high incorporation of co-monomers in the copolymerization of ethylene and an increased thermal stability with respect to the systems so far in use. | 2013-11-28 |
20130317185 | POLYETHYLENE POLYMERISATION IN GAS PHASE REACTOR - A novel gas phase polymerisation method is devised, for polymerisation of low and ultralow density polyethylene. | 2013-11-28 |
20130317186 | LONG CHAIN-BRANCHED ETHYLENE-ALPHA OLEFIN COPOLYMER - The present invention relates to an ethylene-alpha olefin copolymer comprising long chain branches (LCB), while having a narrow molecular weight distribution. The ethylene-alpha olefin copolymer can be prepared by a continuous solution polymerization process using an activated catalyst composition containing a Group 4 transition metal compound having a monocyclopentadienyl ligand, to which a quinoline amino group is introduced. | 2013-11-28 |
20130317187 | LONG CHAIN-BRANCHED ETHYLENE-ALPHA OLEFIN COPOLYMER - The present invention relates to an ethylene-alpha olefin copolymer comprising long chain branches (LCB), while having a narrow molecular weight distribution. The ethylene-alpha olefin copolymer can be prepared by a continuous solution polymerization process using an activated catalyst composition containing a Group 4 transition metal compound having a monocyclopentadienyl ligand, to which a quinoline amino group is introduced. | 2013-11-28 |
20130317188 | CONTROLLED, IMINE BASE-INITIATED POLYMERIZATION - The present invention relates to an innovative polymerization technique for (meth)acrylates or styrenes, in which a special base with imine structure is added as a latent initiator, and the polymerization can be initiated without adding a coinitiator, at high temperatures. With this new and selectively employable technique it is also possible to produce high molecular weight poly(meth)acrylates having in some cases narrow molecular weight distribution. Furthermore, employing this new polymerization technique, a wide variety of different polymer architectures is available, such as block, star, or comb polymers. | 2013-11-28 |
20130317189 | POLYISOBUTYLENE COMPOSITION HAVING INTERNAL VINYLIDENE AND PROCESS FOR PREPARING THE POLYISOBUTYLENE POLYMER COMPOSITION - A polyisobutylene composition has polyisobutylene molecules with a first portion having a alpha vinylidene molecules, a second portion having beta vinylidene molecules, and a third portion having internal vinylidene molecules. The first portion has less than 75% of the polyisobutylene molecules of the composition. A total of the first portion and the. second portion is less than 90% of the polyisobutylene molecules of the composition. The third portion is more than 3% of the polyisobutylene molecules of the composition. A process for forming this polyisobutylene polymer composition passes an isobutylene through a fixed bed reactor having a boron trifluoride/alcohol complex therein so as to produce the polyisobutylene composition. | 2013-11-28 |
20130317190 | COPOLYMERIZABLE SURFACTANTS - The invention relates to the use of compounds of the formula (I), R—CH(O—(AO) | 2013-11-28 |
20130317191 | PROCESSES FOR PREPARING DIACIDS, DIALDEHYDES AND POLYMERS - Alcohols are catalytically oxidized to aldehydes, in particular to benzaldehyde and diformylfuran, which are useful as intermediates for a multiplicity of purposes. The invention also relates to the polymerization of the dialdehyde and to the decarbonylation of the dialdehyde to furan. | 2013-11-28 |
20130317192 | PROCESSES FOR PREPARING DIACIDS, DIALDEHYDES AND POLYMERS - Alcohols are catalytically oxidized to aldehydes, in particular to benzaldehyde and diformylfuran, which are useful as intermediates for a multiplicity of purposes. The invention also relates to the polymerization of the dialdehyde and to the decarbonylation of the dialdehyde to furan. | 2013-11-28 |
20130317193 | PROCESS FOR PREPARING FLOWABLE AMORPHOUS POLY-ALPHA OLEFIN ADHESIVE PELLETS - The present invention relates to a process for producing free-flowing, agglomeration resistant amorphous poly-alpha-olefin based adhesive pellets. The process includes (a) extruding the adhesive through an orifice of a die plate immersed in a cooling fluid; (b) cutting the adhesive into a plurality of pellets in the cooling fluid; (c) solidifying the pellets at a temperature range of about 25° C. to about 40° C. for at least 30 minutes; and (d) separating the pellets from the recrystallization fluid and drying the pellets. The pellets harden at least three folds faster than conventionally formed pellets. | 2013-11-28 |
20130317194 | PROCESS FOR PREPARING CONDENSATION RESINS - The present invention relates to a new process for preparing condensation resins, constructed formally from urea, formaldehyde, and CH-acidic aldehydes. | 2013-11-28 |
20130317195 | HER2DELTA16 PEPTIDES - The present invention provides cyclic peptides comprising a dimer of peptides, each peptide comprising a sequence corresponding to the HER2 splice variant HER2Delta16, wherein the cyclic peptide is cyclized via a disulfide bond between the peptides and via an amino acid linking the peptides. The invention also provides methods of making antibodies that specifically bind to HER2Delta16 homodimers using said cyclic peptides. | 2013-11-28 |
20130317196 | TRIAZANONANE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR ENHANCED FLUORINE-18 LABELING - The present invention relates to a triazanonane derivative indicated by the chemical formula 1 below, or a pharmaceutically acceptable salt thereof, and a method for preparing same, and the triazanonane derivative according to the present invention forms a complex with a metal-fluoride and displays an effect of increasing the labeling efficiency up to 78-90% when labeling F-18, thus enabling use in various radioactive medicine labeling | 2013-11-28 |
20130317197 | METHODS FOR CAPTURING VIRUS LIKE PARTICLES FROM PLANTS USING EXPANDED BED CHROMATOGRPAHY - The present invention relates to a method for capturing virus-like particles of interest from a mixture comprising the use of an expanded bed of adsorbent; suitably wherein said method comprises the steps of: (a) providing an expanded bed of adsorbent; (b) contacting the mixture with the adsorbent such that the constituents of the mixture contact the expanded bed of adsorbent; (c) optionally washing the adsorbent; and (d) optionally eluting the particle of interest from the adsorbent. | 2013-11-28 |
20130317198 | Tandem Purification of Proteins - The present disclosure provides methods for purifying products from a fluid. In some embodiments, provided purification methods use a combination of purification modes (e.g., protein A and ion exchange) operated in tandem, wherein at least one of the modes utilizes weak partitioning. In some embodiments, provided purification methods operate under robust conditions in which a degree of binding between a product and resin is maintained despite variations in operating parameters. | 2013-11-28 |
20130317199 | Antibodies To Alpha-Synuclein - The invention provides methods for detecting alpha-synuclein. The invention also identifies preferred epitopes of alpha synuclein for use in such detection, and provides antibodies specifically binding to such epitopes. | 2013-11-28 |
20130317200 | Methods of Purifying Antibodies - The invention provides methods of purifying antibodies using various antibody-specific purification media to rapidly and efficiently separate mixtures of antibodies, antibody fragments and/or antibody components to isolate a desired antibody product from the mixture. The invention relates to the purification of bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, e.g., antibodies composed of a single heavy chain and two different light chains, one containing a Kappa constant domain and the other a Lambda constant domain, including antibodies of different specificities that share a common heavy chain. The invention also provides the methods of efficiently purifying intact antibodies by separating the intact antibody from non-intact antibodies including free light chains. | 2013-11-28 |
20130317201 | ANTI-CDH3 ANTIBODY HAVING HIGH INTERNALIZATION CAPACITY - It is an object of the present invention to provide an anti-cadherin antibody having a high internalization capacity and provide an anti-cadherin antibody-drug conjugate that effectively kills cadherin-expressing cancer cells with the use of such antibody. The present invention provides an anti-cadherin antibody which recognizes a cadherin domain 1 (EC1) of cadherin and exhibits a high internalization capacity. | 2013-11-28 |
20130317202 | TEST AGENT FOR VISCERAL OBESITY AND USE THEREOF - Disclosed are: a method for detecting (diagnosing) visceral obesity in a subject; a test agent useful for the method; a method for searching for a substance that can be used as an active ingredient for ameliorating visceral obesity; and an ameliorating agent for visceral obesity or a medicinal agent for preventing a metabolic disease developed as a result of the progression of visceral obesity. As the test agent, a polynucleotide which comprises at least 15 nucleotides and can hybridize with a nucleotide sequence for coiled-coil domain containing protein 3 (CCDC3) gene or a nucleotide sequence complementary to the nucleotide sequence under stringent conditions or an antibody capable of recognizing CCDC3 protein is used. | 2013-11-28 |
20130317203 | Anti-IL-6 Receptor Antibody - The present inventors succeeded in discovering specific amino acid mutations in the variable region, framework region, and constant region of TOCILIZUMAB, and this enables to reduce immunogenicity risk and the heterogeneity originated from disulfide bonds in the hinge region, as well as to improve antigen binding activity, pharmacokinetics, stability under acidic conditions, and stability in high concentration preparations. | 2013-11-28 |
20130317204 | Purification of Proteins - The present invention relates to a selectively soluble polymer capable of binding to a desired molecules in an unclarified mixture containing various biological materials and the methods of using such a polymer to purify a molecule from such a mixture. The polymer is soluble in the mixture under a certain set of process conditions such as pH or temperature and/or salt concentration and is rendered insoluble and precipitates out of solution upon a change in the process conditions. The polymer is capable of binding to the desired molecule (protein, polypeptide, etc) and remains capable of binding to that molecule even after the polymer is precipitated out of solution. The precipitate can then be filtered out from the remainder of the stream and the desired biomolecule is recovered such as by elution and further processed. | 2013-11-28 |
20130317205 | Conformationally Specific Viral Immunogens - The present invention provides methods of making engineered viral proteins and protein complexes that are useful as vaccine immunogens, engineered viral proteins and protein complexes made using such methods, and pharmaceutical compositions comprising such engineered viral proteins and protein complexes. Such engineered viral proteins and protein complexes may comprise one or more cross-links that stabilize the conformation of an antibody epitope, such as a quaternary neutralizing antibody, and may exhibit an enhanced ability to elicit a protective immune response when administered to a subject as a component of a vaccine. | 2013-11-28 |
20130317206 | SOLID-PHASE SUPPORT FOR OLIGONUCLEOTIDE SYNTHESIS AND OLIGONUCLEOTIDE SYNTHESIS METHOD - The present invention provides a solid-phase support for oligonucleotide synthesis for synthesizing long chain oligonucleotide, RNA oligonucleotide and modified oligonucleotide at high synthetic quantity and high purity with a low loading amount of a linker. Provided is a solid-phase support for oligonucleotide synthesis comprising a porous resin bead having a monovinyl monomer unit, a crosslinkable vinyl monomer unit and a polyethylene glycol unit and a cleavable linker loaded on its surface, the porous resin bead having a group capable of binding to a carboxy group by a dehydration condensation reaction on its surface, the cleavable linker having a carboxy group, wherein the carboxy group of the cleavable linker is bound to the group capable of binding to a carboxy group, by a dehydration condensation reaction, and a loading amount of the cleavable linker is 1 to 80 μmol/g relative to the weight of the porous resin bead. | 2013-11-28 |
20130317207 | CARBOXY X RHODAMINE ANALOGS - The present invention provides novel fluorescent dyes and kits containing the same, which are useful for labeling a wide variety of biomolecules, cells and microorganisms. The present invention also provides various methods of using the fluorescent dyes for research and development, forensic identification, environmental studies, diagnosis, prognosis and/or treatment of disease conditions. | 2013-11-28 |
20130317208 | METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES - Processes for precipitating a polymer from a polymer-containing fluid are disclosed, which include providing a vessel housing a medium that provides one or more precipitation surfaces. A polymer-containing fluid, e.g., a polymer solution, dispersion or mixed solution/dispersion, and an anti-solvent can be introduced into the vessel so as to cause precipitation of at least a portion of the polymer on at least one of the precipitation surfaces. In some embodiments, the polymer contains one or more cyclic oligosaccharide moieties, such as one or more cyclodextrin moieties (e.g., α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin). The polymer can be any of a linear or branched polymer. The polymer can be any of polycation, a polyanion, or a non-ionic polymer. Also disclosed herein are precipitation surfaces with polymer precipitated thereon. | 2013-11-28 |
20130317209 | METHOD FOR PRODUCING PSEUDOPOLYROTAXANE - The present invention aims to provide an industrially advantageous method of producing a pseudopolyrotaxane with a high inclusion ratio. The present invention relates to a method for producing a pseudopolyrotaxane, including: an inclusion step of mixing a polyethylene glycol and a cyclodextrin in an aqueous medium to form an aqueous dispersion of pseudopolyrotaxane that contains pseudopolyrotaxane particles in which the polyethylene glycol is included in the cavities of the cyclodextrin molecules in a skewered manner; and a drying step of drying the aqueous dispersion of pseudopolyrotaxane produced in the inclusion step to obtain the pseudopolyrotaxane. In the drying step, the aqueous dispersion of pseudopolyrotaxane is dried in a thin film state. | 2013-11-28 |
20130317210 | Tagatose production using simulated moving bed separation - Disclosed is a process for the production of d-tagatose from lactose after acid hydrolysis to provide a hydrolysate having 1 equiv of d-glucose and 1 equiv of d-galactose for each unit of lactose converted. More particularly, the invention relates to a process for the isomerization of d-galactose to d-tagatose and the use of a simplified separation scheme based on simulated moving bed (SMB) separation. The isomerization of d-galactose to d-tagatose is carried out in the presence of calcium oxide or calcium hydroxide. The process is useful for providing a simplified processing route to providing pure d-tagatose and glucose as two products from lactose hydrolysate. In an alternate embodiment, a process is disclosed for the production of d-tagatose from fermented lactose hydrolysate to provide a crystallized d-tagatose product. D-tagatose is useful as a food additive, as a sweetener, as a texturizer, as a stabilizer, or as a humectant. | 2013-11-28 |
20130317211 | Pyrrolo[2,1-c][1,4]naphthodiazepine Linked Piperazine Compounds and a Process for the Preparation Thereof - The present invention provides a compound of general formula A, useful as potential antitumour agents against five human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]naphthodiazepine linked substituted piperazine conjugates attached through different alkane spacers of general formula A. (Formula I) General formula A. Where R=R′=(Formula II). n=1-9 and R″=methyl, ethyl, acetyl, benzyl, piperinoyl, 4-fluorophenyl, 4-chlorophenyl, 4-methoxyphenyl, pyridyl, pyrimidyl | 2013-11-28 |
20130317212 | LIGHT EMITTING MATERIALS FOR ELECTRONICS - The present invention relates to an organometallic complex, to the preparation of said material, to the use of said material and to a light emitting device which transform electric energy into light. The present invention is further related to provide phosphorescent complexes which contribute to extend the life time in operation of said OLEDs and especially when they are involved in the EL. The objectives of this invention are accomplished by iridium complex comprising 7-membered fused ring ligands which are tris-homoleptic or bis-homoleptic with an ancillary ligand. | 2013-11-28 |
20130317213 | Hepatitis C Virus Inhibitors - The present disclosure relates to methods for making compounds useful in the treatment of Hepatitis C virus (HCV) infection. | 2013-11-28 |
20130317214 | METHOD FOR PRODUCING MALEATE USING WET CRYSTAL - [Problem] To efficiently (without carrying out column purification) provide a high-purity maleate having excellent storage stability, solubility, crystallinity and ease of handling according to the present invention. | 2013-11-28 |
20130317215 | STABLE SYNTHETIC INTERMEDIATE AND METHOD FOR MANUFACTURING SAME | 2013-11-28 |
20130317216 | 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES - The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades. | 2013-11-28 |
20130317217 | AFFINITY ADSORBENTS FOR FIBRINOGEN - For the separation, removal, isolation, purification, characterisation, identification or quantification of fibrinogen or a protein that is a fibrinogen analogue, an affinity adsorbent is used that is a compound of formula II | 2013-11-28 |
20130317218 | NOVEL BICYCLIC THIAZOLE COMPOUNDS - The present invention relates to novel bicyclic thiazole compounds that inhibit Traf2- and Nck-interacting kinase (TNIK), and as such are useful as TNIK inhibitors administered to cancer patients, especially to solid cancer patients such as colorectal cancer, pancreatic cancer, non-small cell lung cancer, prostate cancer or breast cancer. The bicyclic thiazole compounds are showed by a next formula (I). | 2013-11-28 |
20130317219 | Benzothiazole Derivatives - Provided are compounds and their pharmaceutically acceptable salts that are useful for the treatment of diseases related to the adenosine receptor. Also included are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance. | 2013-11-28 |
20130317220 | NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF - Provided herein is a novel process for the preparation of triazolo[4,5-d]pyrimidine derivatives. Provided particularly herein is a novel, commercially viable and industrially advantageous process for the preparation of highly pure ticagrelor or a pharmaceutically acceptable salt thereof. Provided further herein is a novel process for the preparation of substituted cyclopentanamine derivatives, which are useful intermediates in the preparation of triazolo[4,5-d]pyrimidine compounds. Provided particularly herein is a novel, commercially viable and industrially advantageous process for the preparation of a ticagrelor intermediate, 2-[[(3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]-dioxol-4-yl]oxy]-1-ethanol. | 2013-11-28 |
20130317221 | 3-ARYLETHYNYL SUBSTITUTED QUINAZOLINONE COMPOUNDS - The present invention provides 3-arylethynyl substituted quinazolinone compounds of formula (A) as potential anticancer agents against sixty human cancer cell lines. R | 2013-11-28 |
20130317222 | SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-1-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYD- ROFURAN-2-YL]-1H-BENZIMIDAZOL-2-YL]UREA - The present application is directed to solid forms of compounds of formula (I): | 2013-11-28 |
20130317223 | Slow Release of Organoboronic Acids in Cross-Coupling Reactions - A method of performing a chemical reaction includes reacting a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and a protected organoboronic acid represented by formula (I) in a reaction mixture: | 2013-11-28 |
20130317224 | NOVEL NI COMPLEX AND ITS DERIVATIVES, PRODUCING METHOD, AND THE USE THEREOF AS AN ANTIOXIDANT - The present invention relates to a novel nickel complex and its derivatives, which mimic the active site of Ni-containing superoxide dismutase (NiSOD). The five-coordinate Ni(II) and Ni(III) complexes or their derivatives, and six-coordinate derivatives have the following structures of formula (I) and (II): | 2013-11-28 |
20130317225 | NEW FORMS OF RIFAXIMIN AND USES THEROF - The present invention relates to new rifaximin forms kappa, theta, rifaximin:piperazine cocrystal 1 and rifaximin:piperazine cocrystal 2, methods of making same and to their use in medicinal preparations and therapeutic methods. | 2013-11-28 |
20130317226 | INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER - The present invention relates to the use of the Sigma-1 receptor (Sig1R) in the context of the post-transcriptional regulation of the membrane expression of ion channels. | 2013-11-28 |
20130317227 | PROCESS FOR MAKING A SOLID-STATE FORM OF AMG 706 - The anti-angiogenic drug AMG 706 is provided in amorphous form. Also provided is AMG 706 drug substance wherein the AMG 706 is present, in at least a detectable amount, as amorphous AMG 706. Also provided is an AMG 706-crystallization inhibitor composite comprising particles of amorphous AMG 706 or a AMG 706 drug substance of the invention in intimate association with one or more crystallization inhibitors, for example polymers. Also provided is a pharmaceutical composition comprising such an AMG 706-crystallization inhibitor composite and one or more excipients. Also provided are processes for preparing amorphous AMG 706, AMG 706 drug substance of the invention, an AMG 706-crystallization inhibitor composite of the invention, and a pharmaceutical composition of the invention. Also provided is a method of treating a medical condition or disorder in a subject where treatment with an anti-angiogenic is indicated, comprising administering, for example orally, a composition of the invention in a therapeutically effective amount. | 2013-11-28 |
20130317228 | AZOLIUM METAL-ORGANIC FRAMEWORKS - Disclosed herein are metal-organic frameworks comprising at least two azolium rings. The azolium groups are used as a strategy for controlling catenation and morphology in metal-organic frameworks. | 2013-11-28 |
20130317229 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND - An optical film comprising at least one compound represented by formula (1) is disclosed. In the formula, Y | 2013-11-28 |
20130317230 | Process For The Preparation Of Azilsartan Medoxomil - The present invention relates to an improved process for the preparation of azilsartan or its esters or salts thereof. Specifically, the invention provides a method for the preparation of highly pure methyl 1-[[2′-(4,5-dihydro-5-oxo-4H-1,2,4-oxa-diazol-3-yl)biphenyl-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate an intermediate compound of formula (4) for azilsartan medoxomil with reduced content of desethyl impurity. The invention also involves the use of highly pure methyl 1-[[2′-(4,5-dihydro-5-oxo-4H-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate in the preparation of azilsartan or its esters or salts thereof, preferably medoxomil with reduced content of desethyl impurity. | 2013-11-28 |
20130317231 | Amidobenzothiazoles And Process For The Preparation Thereof - The present invention provides a compound of general formulae A useful as potential anti-cancer agents against human cancer cell lines and a process for the preparation thereof. Where in R, R | 2013-11-28 |
20130317232 | ALTERNATIVE TO TETRAZENE - Embodiments of materials suitable for use as a replacement for Tetrazene and methods of preparing such materials are described. In one embodiment, the material comprises MTX-1, as well as simple salts or complexes derived therefrom. The methods of preparing such materials include combining Tetrazene and an acid to form a suspension, where the acid is nitric acid, sulfuric acid, perchloric acid, or hydrochloric acid. A nitrite salt may be added to the suspension, where the nitrite salt is sodium nitrite, lithium nitrite, potassium nitrite, an aqueous solution of sodium nitrite, an aqueous solution of lithium nitrite, or an aqueous solution of potassium nitrite. In some embodiments, the suspension is stirred until the suspension has a white appearance. | 2013-11-28 |
20130317233 | Electroluminescent Materials - Compounds of the general structure: Z-A-(S—B) | 2013-11-28 |
20130317234 | Process for Preparation of Intermediates of Bendamustine - The present invention relates to a process for the preparation of 4-{5-{Bis-(2-hydroxyl-ethyl)-amino}-1-methyl-1H-Benzoimidazol-2yl}-butyric acid alkyl ester of formula IV, a key intermediate in the process for the preparation of Bendamustine HCl (I) | 2013-11-28 |
20130317235 | PROCESS FOR THE PREPARATION OF (1S, 3S, 5S)-2-[2(S)-2-AMINO-2-(3-HYDROXY-1-ADAMANTAN-1-YL ACETYL]-2-AZABICYCLO [3.1.0] HEXANE-3-CARBONITRILE - The present invention relates to an improved process for the preparation of (1S,3S,5S)-242(S)-2-amino-2-(3-hydroxy-1-adamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile and its intermediates. | 2013-11-28 |
20130317236 | CRYSTALLINE FOSAMPRENAVIR CALCIUM AND PROCESS FOR THE PREPARATION THEREOF - The main object of the present invention relates to novel crystalline form of Fosamprenavir Calcium designated as Form A. Another object of the present invention relates to a process for the preparation of Crystalline Form A of Fosamprenavir Calcium. Yet another object of the present invention relates to crystalline Form A of Fosamprenavir Calcium characterized by an PXRD diffraction having reflections at about 3.1±0.2, 4.4±0.2, 5.0±0.2, 6.3±0.2, 7.4±0.2, 8.0±0.2, 28. | 2013-11-28 |
20130317237 | SYNTEHSIS OF CYCLIC CARBONATES - A dimeric aluminium(salen) catalyst of formula I: | 2013-11-28 |
20130317238 | DEPOLYMERIZATION PROCESSES, APPARATUSES AND CATALYSTS FOR USE IN CONNECTION THEREWITH - The present disclosure generally relates to processes, apparatuses and custom catalysts designed to depolymerize a polymer. In one embodiment, the present invention relates to a de-polymerizing apparatus, catalysts and reaction schemes to obtain useful monomers including fuel products by “in situ” reactions using coupled electromagnetic induction. | 2013-11-28 |
20130317239 | METHOD FOR PRODUCING 2-FURALDEHYDE - An object of the present invention is to provide a method for suppressing the corrosion of a reactor and reducing waste in the production of 2-furaldehyde from a sugar raw material containing a hexose as a constituent component, and another object of the invention is to provide an industrially advantageous method for producing 2-furaldehyde, which suppresses a decrease in the activity of a catalyst in a case of using an acid catalyst and provides a higher yield. The present invention relates to a method for producing 2-furaldehyde comprising heating a sugar raw material containing a hexose as a constituent component in an aprotic polar solvent in the presence of a solid acid catalyst. | 2013-11-28 |
20130317240 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 2013-11-28 |
20130317241 | PROCESS FOR CONCENTRATING OMEGA-3 FATTY ACIDS - The present disclosure relates generally to processes for concentrating omega-3 fatty acids from a fatty acid oil mixture with an aqueous silver salt, such as an aqueous AgNO | 2013-11-28 |
20130317242 | NICKEL COMPOSITIONS FOR PREPARING NICKEL METAL AND NICKEL COMPLEXES - Nickel(II) compositions for use in manufacturing nickel metal (Ni(0)) compositions, and specifically to methods of making basic nickel carbonates used to produce nickel metal compositions are disclosed. By varying the molar ratios of carbonates and bicarbonates to nickel salts, the methods provide basic nickel carbonates that produce superior nickel metal-containing solids that are well-suited to forming nickel-ligand complexes with phosphorus-containing ligands. The phosphorus-containing ligands can be monodentate or bidentate phosphorus-containing ligands. | 2013-11-28 |
20130317243 | Polysiloxane-N, N-Dihydrocarbylene Sugar-Modified Multiblock Copolymer And Method For Producing The Same - The present invention provides a novel and stable organopolysiloxane, which has both hydrophobic properties and hydrophilic properties and exhibits reduced hydrolysis properties, and provides a preparation method capable of easily synthesizing the aforementioned organopolysiloxane without using complicated and/or troublesome operations. A polysiloxane-N,N-dihydrocarbylene sugar-modified multiblock copolymer is obtained by reacting a polysiloxane-hydrocarbylene aminohydrocarbylene multiblock copolymer having a secondary amino group with a sugar acid or an intramolecular dehydration cyclic product thereof. | 2013-11-28 |
20130317244 | ORGANIC-INORGANIC HYBRID CHIRAL SORBENT AND PROCESS FOR THE PREPARATION THEREOF - The present invention provides an organic-inorganic hybrid chiral sorbent for chiral resolution of various racemic compounds viz. racemic mandelic acid, 2-phenyl propionic acid, diethyl tartrate, 2,2′-dihydroxy-1,1′-binaphthalene (BINOL) and cyano chromene oxide with excellent chiral separation (enantiomeric excess, 99%) in case of mandelic acid under medium pressure column chromatography. These optically pure enantiomers find applications as intermediates in pharmaceutical industries. | 2013-11-28 |
20130317245 | INTERMEDIATES FOR THE SYNTHESIS OF BENZINDENE PROSTAGLANDINS AND PREPARATIONS THEREOF - Novel processes for preparing optically active cyclopentanones 1 | 2013-11-28 |
20130317246 | METHOD FOR THE PURIFICATION OF BIPHEPHOS - The invention relates to a process for the purification of 6,6′-[(3,3′-di-tert-butyl-5,5′-dimethoxy-1,1′-biphenyl-2,2′diyl)bis(oxy)]bis(dibenzo[d,f][1,3,2]dioxaphosphepin), abbreviation: biphephos (see formula 1). | 2013-11-28 |
20130317247 | PROCESS FOR PRODUCTION OF AROMATIC AMIDE CARBOXYLIC ACID DERIVATIVE - The invention provides a method for producing an aromatic amide carboxylic acid derivative represented by the following Formula (2), including a step of reacting an aromatic amide halide derivative represented by the following Formula (1) with carbon monoxide. In the following Formulae (1) and (2), R | 2013-11-28 |
20130317248 | STABILIZED ISOCYANATE GROUP-CONTAINING ETHYLENICALLY UNSATURATED COMPOUND - An object of the present invention is to improve the stability of an ethylenically unsaturated compound having an isocyanate group in the molecule by preventing a polymerization of the ethylenically unsaturated compound. The present invention relates to a stabilizing composition for an isocyanate group-containing ethylenically unsaturated compound, comprising: an isocyanate group-containing ethylenically unsaturated compound (A) which comprises one or more isocyanate groups and one or more ethylenically unsaturated groups in the molecule; and a stabilizing agent (B) which is a compound in which at least one of the ethylenically unsaturated groups in the compound (A) is replaced with an alkyl group which may have a substituent. | 2013-11-28 |
20130317249 | METHOD FOR THE PURIFICATION OF PROSTAGLANDINS - The present invention provides a method for the purification of a prostaglandin by supercritical fluid chromatography, said method comprising the use of a stationary phase and a mobile phase comprising carbon dioxide, provided that when the stationary phase is unmodified silica gel, the prostaglandin is not luprostiol. The invention also provides prostaglandins obtainable by the method. | 2013-11-28 |
20130317250 | 2-(Alkylcarbonyloxy)-1, 1-Difluoroethanesulfonic Acid Salt and Method for Producing the Same - By using an organic base when a carboxylic acid bromodifluoroethyl ester is sulfinated by using a sulfinating agent, there is obtained 2-(alkylcarbonyloxy)-1,1-difluoroethanesulfinic acid ammonium salt. By oxidizing the 2-(alkylcarbonyloxy)-1,1-difluoroethanesulfinic acid ammonium salt, there is obtained 2-(alkylcarbonyloxy)-1,1-difluoroethanesulfonic acid ammonium salt. By using the 2-(alkylcarbonyloxy)-1,1-difluoroethanesulfonic acid ammonium salt as a raw material and exchanging it into an onium salt directly or through saponification/esterification, there can be obtained a 2-alkylcarbonyloxy-1,1-difluoroethanesulfonic acid onium salt. | 2013-11-28 |
20130317251 | Process for the manufacture of fluoromethoxymalonic acid derivatives - Process for the manufacture of a compound of formula R | 2013-11-28 |
20130317252 | STABILIZED ISOCYANATE GROUP-CONTAINING ETHYLENICALLY UNSATURATED COMPOUND - An object of the present invention is to improve the stability of an ethylenically unsaturated compound having an isocyanate group in the molecule by preventing a polymerization, a multimerization reaction and a discoloration reaction of the ethylenically unsaturated compound. The present invention relates to a stabilizing composition for an isocyanate group-containing ethylenically unsaturated compound, comprising: an isocyanate group-containing ethylenically unsaturated compound (A) which comprises one or more isocyanate groups and one or more ethylenically unsaturated groups in the molecule; and a stabilizing agent (B) which is a compound in which at least one of the ethylenically unsaturated groups in the compound (A) is replaced with an alkyl halide group or an amino alkyl group which may have a substituent. | 2013-11-28 |
20130317253 | PROCESS FOR CONTINUOUS RECOVERING (METH) ACRYLIC ACID AND APPARATUS FOR THE PROCESS (AS AMENDED) - The present invention relates to a method and apparatus for continuous recovery of (meth)acrylic acid, and more specifically to a method of continuous recovery of (meth)acrylic acid, including: conducting gas phase oxidation of at least one compound selected from the group consisting of propane, propylene, butane, i-butylene, t-butylene, and (meth)acrolein in the presence of a catalyst to obtain a mixed gas containing (meth)acrylic acid; quenching the (meth)acrylic acid-containing mixed gas to remove high boiling point by-products in the (meth)acrylic acid-containing mixed gas; contacting the high boiling point by-product-free (meth)acrylic acid-containing mixed gas with water or an aqueous solution to obtain an aqueous solution containing (meth)acrylic acid; and purifying the aqueous solution containing (meth)acrylic acid to obtain (meth)acrylic acid. | 2013-11-28 |
20130317254 | Process for Producing Acrylic Acids and Acrylates - In one embodiment, the invention is to a process for producing an acrylate product. The process comprises the step of providing a crude product stream comprising the acrylate product and an alkylenating agent. The process further comprises the step of separating at least a portion of the crude product stream into an intermediate acrylate product stream and an alkylenating stream. The process further comprises separating at least a portion of the intermediate acrylate product stream by azeotropic distillation in the presences of an entrainer to form a stream containing acrylate product and a stream containing entrainer. | 2013-11-28 |
20130317255 | PROCESS FOR THE PREPARATION OF ROTIGOTINE - A process for the preparation of Rotigotine (1) | 2013-11-28 |
20130317256 | CATALYST COMPOSITIONS FOR HYDROFORMYLATION REACTION AND HYDROFORMYLATION PROCESS USING THE SAME - Disclosed are a catalyst composition for hydroformylation of olefin compounds, comprising a specific phosphine ligand and a transition metal catalyst, and a hydroformylation process using the same. Through a hydroformylation process using the catalyst composition according to the present invention, a suitable selectivity of iso-aldehyde can be maintained, catalyst stability can be improved, the amount of used ligand can be reduced and superior catalyst activity can be obtained. | 2013-11-28 |
20130317257 | PERFLUOROPOLYETHER LUBRICANT AND SYSTEMS COMPRISING SAME - A surface agent includes two end portions and a middle portion disposed between the end portions. The end portions include a terminal section and a midsection. The terminal section includes at least one surface active functional group. The midsection includes at least one perfluoroethyl ether unit. The middle portion includes at least one perfluorobutyl ether unit. | 2013-11-28 |